BioSpace News Archive

New targets supported by climate science

The vast majority of people who undergo total knee replacement surgery have high satisfaction following the procedure;

This meeting will focus on advances in treatment and management to reduce cost and improve outcomes in patients with diabetes

The InSite® In-Facility Medication Packaging and Dispensing Service enables long-term care pharmacies to differentiate services while minimizing risks of technology adoption

MCRA, LLC, a leading medical device consulting firm and clinical research organization (CRO) that integrates regulatory, clinical research, reimbursement, compliance and quality assurance, is pleased to announce the expansion of its cardiovascular consulting activities through the hiring of Michael C. John, MPH, as its new Vice President of Cardiovascular Regulatory Affairs.

“RadioRev,” a new podcast from Revel, a leading health action platform, has launched a new podcast featuring a series of in depth interviews with leading innovators who are bringing new ideas, inspiring others and leading the way within the healthcare industry

Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., together with Kohl’s (NYSE: KSS) announced a strategic collaboration to initially open up to 10 Planet Fitness stores adjacent to select Kohl’s stores across the country in 2019 with the opportunity for additional locations in the future.

A new enterprise that promises to redefine the traditional model of healthcare industry consulting has recently launched. Excelerant Consulting, LLC is a full-service provider specializing in taking products to market faster while accelerating sales and profitability in a rapidly changing, increasingly complex healthcare supply chain.

Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced that Sanjiv K. Patel, M.A., M.D., MBA, president and chief executive officer, will present a company overview at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019 at 11:30 a.m. ET.

MYR Pharma announced today that the British Medicines and Healthcare products Regulatory Agency (MHRA) has issued the Promising Innovative Medicine (PIM) designation for MYR’s lead compound Bulevirtide (Myrcludex)